Premium
Further delineation of the GDF6 related multiple synostoses syndrome
Author(s) -
Terhal Paulien A.,
Verbeek Nienke E.,
Knoers Nine,
Nievelstein Rutger J. A. J.,
van den Ouweland Ans,
Sakkers Ralph J.,
Speleman Lucienne,
van Haaften Gijs
Publication year - 2018
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.38503
Subject(s) - hearing loss , medicine , amelogenesis imperfecta , synostosis , otosclerosis , sensorineural hearing loss , genetics , phenotype , dysostosis , biology , audiology , dentistry , congenital disease , enamel paint , gene
A mutation in GDF6 was recently found to underlie a multiple synostoses syndrome. In this report, we describe the second family with GDF6‐related multiple synostoses syndrome (SYNS4), caused by a novel c.1287C>A/p.Ser429Arg mutation in GDF6 . In addition to synostoses of carpal and/or tarsal bones, at least 6 of 10 affected patients in this family have been diagnosed with mild to moderate hearing loss. In four of them otosclerosis was said to be present, one patient had hearing loss due to severe stapes fixation at the age of 6 years, providing evidence that hearing loss in the GDF6‐related multiple synostoses syndrome can be present in childhood. Two others had surgery for stapes fixation at adult age. We hypothesize that, identical to the recently published GDF6‐related multiple synostoses family, the p.Ser429Arg mutation also leads to a gain of function. The previously reported c.1330T>A/pTyr444Asn mutation was located in a predicted Noggin and receptor I interacting domain and the gain of function was partly due to resistance of the mutant GDF6 to the BMP‐inhibitor Noggin. The results in our family show that mutations predicting to affect the type II receptor interface can lead to a similar phenotype and that otosclerosis presenting in childhood can be part of the GDF6‐related multiple synostoses syndrome.